Baxter (NYSE:BAX) announced today that the FDA granted 510(k) clearance for its Novum IQ large-volume infusion pump (LVP) with Dose IQ safety software.
Clearance adds the LVP to the Novum IQ platform, which already includes the Baxter syringe infusion pump (SYR). It enables clinicians to utilize a single, integrated system across a variety of patient care settings. The integrated user experience helps to reduce the burden of non-critical tasks, allowing for more focus on patient care.
Baxter said its new platform offers a common user interface with a digital, on-screen barcode. It streamlines training and reduces the cognitive burden associated with operating multiple, disparate pump platforms.
Get the full story at our sister site, Drug Delivery Business News.